Research Article
A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma
Table 1
Clinicopathologic data of TCGA cohort and GEO cohort.
| | Variables | TCGA cohort | GSE39582 cohort | GSE17538 cohort |
| | Age | | | | | Gender | | | | | Male | 205 (53.2%) | 322 (55.0%) | 122 (52.6%) | | Female | 180 (46.8%) | 263 (45.0%) | 110 (47.4%) | | Grade | | | | | G1 | — | — | 17 (7.3%) | | G2 | — | — | 166 (71.6%) | | G3 | — | — | 30 (12.9%) | | G4 | — | — | 0 (0%) | | Unknown | — | — | 19 (8.2%) | | Stage | | | | | I | 66 (17.1%) | 28 (17.1%) | 28 (12.1%) | | II | 151 (39.2%) | 72 (17.1%) | 72 (31.0%) | | III | 103 (26.8%) | 76 (17.1%) | 76 (32.8%) | | IV | 54 (14.0%) | 56 (17.1%) | 56 (24.1%) | | Unknown | 11 (2.9%) | 0 (0%) | 0 (0%) | | T stage | | | | | T0 | 0 (0%) | 1 (0.2%) | — | | Tis | 1 (0.3%) | 3 (0.5%) | — | | T1 | 9 (2.3%) | 12 (2.0%) | — | | T2 | 68 (17.7%) | 49 (8.4%) | — | | T3 | 263 (68.3%) | 379 (64.8%) | — | | T4 | 44 (11.4%) | 119 (20.3%) | — | | Unknown | 0 (0%) | 22 (3.8%) | — | | N stage | | | | | N0 | 231 (60.0%) | 314 (53.7%) | — | | N1 | 88 (22.9%) | 137 (23.4%) | — | | N2 | 66 (17.1%) | 100 (17.1%) | — | | N3 | 0 (0%) | 6 (1.0%) | — | | Unknown | 0 (0%) | 28 (4.8%) | — | | M stage | | | | | M0 | 286 (74.3%) | 499 (85.3%) | — | | M1 | 54 (14.0%) | 61 (10.4%) | — | | Unknown | 45 (11.7%) | 25 (4.3%) | — | | Tumor location | | | | | Distal | — | 351 (60.0%) | — | | Proximal | — | 232 (39.7%) | — | | Unknown | — | 2 (0.3%) | — | | Chemotherapy adjuvant | | | | | Yes | — | 240 (41.0%) | — | | No | — | 326 (55.7%) | — | | Unknown | — | 19 (3.3%) | — | | Survival | | | | | Yes | 79 (20.5%) | 194 (33.2%) | 93 (40.1%) | | No | 306 (79.5%) | 385 (65.8%) | 139 (59.9%) | | Unknown | 0 (0%) | 6 (1.0%) | 0 (0%) |
|
|
